Tamoxifen and the female reproductive tract

Author： Mount Sharon L Eltabbakh Gamal H

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.9, 2001-09, pp. : 1399-1413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract

Current Drug Targets, Vol. 12, Iss. 9, 2011-08 ,pp. : 1291-1302

Bentham Science Publishers

Access to resources Recommend Favorite

The Biology of the Peroxisome Proliferator-activated Receptor System in the Female Reproductive Tract

Current Pharmaceutical Design, Vol. 19, Iss. 25, 2013-08 ,pp. : 4641-4646

Bentham Science Publishers

Access to resources Recommend Favorite

Cytolipotoxicity-induced involution of the female reproductive tract following expression of obese (ob/ob) and diabetes (db/db) genotype mutations: progressive, hyperlipidemic transformation into adipocytic tissues

By Garris D.R. Garris B.L.

Reproductive Toxicology, Vol. 18, Iss. 1, 2004-01 ,pp. : 81-91

Elsevier

Access to resources Recommend Favorite

Kallikreins and Kinins in Inflammatory-Like Events in the Reproductive Tract

By Clements J. Mukhtar A. Yan S. Holland A.

Pharmacological Research, Vol. 35, Iss. 6, 1997-06 ,pp. : 537-540

Academic Press

Access to resources Recommend Favorite

Protective role of thymoquinone against liver damage induced by tamoxifen in female rats

By Suddek Ghada M.

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 8, 2014-01 ,pp. : 640-644

NRC Research Press

Access to resources Recommend Favorite